Portal Login:
  • Clients
  • Providers
  • Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
    Portal Login:
  • Clients
  • Providers
  • About MCN
  • Careers
  • MCNTalk
  • Contact Us

MCN | Medical Consultants Network

The Power of a Second Look

  • Services
    • Independent Medical Examinations
    • Medical Peer Reviews
    • Bill Review Services
    • Utilization Reviews
  • Expertise
    • Short and Long-Term Disability
    • Workers’ Compensation
    • Auto/PIP/Casualty/Liability
    • Independent Review Organization Services
  • For Clients
  • For Providers
  • Your Exam
    • About Your Exam
    • About Your External Review
    • Contact & Scheduling
  • Schedule Now
  • About MCN
  • MCNTalk
  • Careers
  • Contact Us

MCNTalk
News, Insights & Opinions

Home / MCNTalk / OxyContin: the strange saga of Purdue and its $3 billion dru...

December 5, 2011

OxyContin: the strange saga of Purdue and its $3 billion drug

“Their chemical composition is such that the U.S. is just a few carbon molecules from being a nation of heroin addicts.”

That’s a pretty harsh quote from this recent article from CNN. And it’s just the start in this latest entry about the U. S. and our dependence on prescription pain killers. Some facts to back up this assertion:

  • 254 million prescriptions for opioids were filled in the U.S. in 2010, according to Wall Street analysts Cowen & Co.
  • Enough painkillers were prescribed in 2010 to “medicate every American adult around the clock for a month,” the federal Centers for Disease Control reported on Nov. 1.
  • It estimated that “non-medical use of prescription painkillers costs health insurers up to $72.5 billion annually in direct health care costs.”
  • Opioids generated $11 billion in revenues for pharmaceutical companies, says market research firm Frost & Sullivan.
  • 15,000 Americans died of opioid overdoses in 2008
  • Two decades ago opioid sales were a small fraction of today’s figures, as such drugs were reserved for the worst cancer pain.

Why this recent spate of attention on Purdue Pharma, the makers of OxyContin? Last year they began selling a reformulated version that should help reduce the worst form of abuse. The original drug had a time-release mechanism that could be defeated by crushing the pill and snorting it, smoking it, or adding water to the powder and injecting it for a heroin-like high. By contrast, the new version breaks into chunks rather than a powder; if water is added, the result is a gelatinous goop. But at the same time, taking that step lifts a stigma from the drug and may make doctors more comfortable prescribing it, an outcome Purdue is hoping for. The result could be an even greater number of invisible addicts. Read more…

47.608945-122.332015

Share this:

  • Twitter
  • Email
  • More
  • Facebook
  • Reddit
  • Print

Tagged: Health Policy, Legal Issues, Lifestyle and habits Leave a Comment

Previous Post
Next Post

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Recent Posts

  • The Quality Divide: What Makes a Quality IME Physician?
  • The Quality Divide: Is Your Vendor Driving IME Excellence?
  • The Quality Divide: When and How to Request an IME?
  • April Clinic Calendars Are Available
  • MCN’s Client Portal Login Page is Changing

Archives

Footer


  • Twitter
  • LinkedIn

Quick Links

  • Services
  • Expertise
  • About MCN
  • Careers

Division Headquarters

MCN
1200 5th Ave., Ste. 650
Seattle, WA 98101

See all offices

Email Us

General Inquiries: info@mcn.com
Sales & Marketing: marketing@mcn.com

Call Us

206.343.6100
800.248.6269

© Copyright 2023 Mitchell International, Inc. All Rights Reserved.

  • Privacy Policy
  • Sitemap